| Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|
 Filter
|
Yasutaka Yamada
|
|||||||
| GSE216050 |
DNA methylation as a therapeutic target in RB1 deficient and neuroendocrine prostate cancer and rational co-targeting with B7-H3 [RRBS]
|
6 | Yasutaka Yamada | Mar 27, 2024 | ||||
| GSE216052 |
DNA methylation as a therapeutic target in RB1 deficient and neuroendocrine prostate cancer and rational co-targeting with B7-H3 [RNA-Seq 1]
|
9 | Yasutaka Yamada | Mar 27, 2024 | ||||
| GSE216053 |
DNA methylation as a therapeutic target in RB1 deficient and neuroendocrine prostate cancer and rational co-targeting with B7-H3 [RNA-Seq 2]
|
6 | Yasutaka Yamada | Mar 27, 2024 | ||||
| GSE216054 |
DNA methylation as a therapeutic target in RB1 deficient and neuroendocrine prostate cancer and rational co-targeting with B7-H3
|
31 | Yasutaka Yamada | Mar 27, 2024 | ||||
| GSE216712 |
DNA methylation as a therapeutic target in RB1 deficient and neuroendocrine prostate cancer and rational co-targeting with B7-H3 [22Rv1sgCD276]
|
4 | Yasutaka Yamada | Mar 27, 2024 | ||||
| GSE216713 |
DNA methylation as a therapeutic target in RB1 deficient and neuroendocrine prostate cancer and rational co-targeting with B7-H3 [22Rv1sgRB1]
|
6 | Yasutaka Yamada | Mar 27, 2024 |
